Actively Recruiting
Post-acute COVID-19 Sequelae in Denmark
Led by Hvidovre University Hospital · Updated on 2025-03-12
800
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Since the first SARS-CoV-2 cases in 2019, over 660 million COVID-19 cases have been reported globally, including 183 million in the EU. Up to 70% of those infected experience reduced organ function four months or more after a COVID-19 diagnosis, potentially increasing the risk of non-communicable diseases (NCDs). The post-acute phase (PAP) after COVID-19 (four months or more after the acute phase) can lead to impaired function in various organ systems, with a focus on the lungs, cardiovascular system, and kidneys. These three NCDs collectively impose a significant burden on individuals and society. Urgently, we need to understand the connection between COVID-19, PAP and NCDs, identifying robust biomarkers for early detection. This study examines PAP and associated risk factors, investigating the link between PAP and the heightened risk of lung, heart, and kidney complications. Utilizing data from a cohort of COVID-19 patients and a control group with respiratory diseases, the study aims to determine prevalence and risk ratios more precisely. The aim is to contribute to minimizing the risk of NCD development or exacerbation in current and future COVID-19 patients, enhancing our understanding of chronic disease development at the population leve
CONDITIONS
Official Title
Post-acute COVID-19 Sequelae in Denmark
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Has a blood sample in the clinical biobank related to the OBS-COVID index admission
- Aged above 18 years at time of index-admission
You will not qualify if you...
- Patients without a Danish personal identification number
- Patients who do not understand or speak Danish
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Copenhagen University Hospital, Amager and Hvidovre
Hvidovre, Denmark, 2650
Actively Recruiting
Research Team
O
Ove Andersen, Professor
CONTACT
M
Mette Bendtz Lindstroem, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here